Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S4W-20625 · Session 4

What its position is on prescribing the medicinal cannabis compound, Sativex, and whether it plans to carry out research on its effectivene…

Answered Asked by Nanette Milne Con Lodged 3 Apr 2014

The question

To ask the Scottish Government what its position is on prescribing the medicinal cannabis compound, Sativex, and whether it plans to carry out research on its effectiveness in the treatment of people with (a) multiple sclerosis and (b) fibromyalgia.

The answer

Answered by Alex Neil on 24 Apr 2014 · 21 days after it was lodged, on time

The manufacturer of Sativex has not provided a submission to the Scottish Medicines Consortium. Therefore, Sativex is not currently recommended for use within the NHS in Scotland.
The Chief Scientist Office (CSO) within the Scottish Government has responsibility for encouraging and supporting research into health and healthcare needs in Scotland. CSO responds primarily to requests for funding research proposals initiated by the research community in Scotland. CSO is not currently funding any research projects regarding the potential medical use of cannabis. CSO would welcome research proposals in this area which would be subject to the usual peer and committee review.

In the Official Report

No contribution in the Official Report cites S4W-20625 by reference.